WO2006089215A3 - Compositions pharmaceutiques et procedes associes - Google Patents

Compositions pharmaceutiques et procedes associes Download PDF

Info

Publication number
WO2006089215A3
WO2006089215A3 PCT/US2006/005821 US2006005821W WO2006089215A3 WO 2006089215 A3 WO2006089215 A3 WO 2006089215A3 US 2006005821 W US2006005821 W US 2006005821W WO 2006089215 A3 WO2006089215 A3 WO 2006089215A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
pharmaceutical compositions
disclosed
effective amount
composition
Prior art date
Application number
PCT/US2006/005821
Other languages
English (en)
Other versions
WO2006089215A2 (fr
Inventor
Vinod V Tuliani
Michael A Brandley
Original Assignee
Glaxo Group Ltd
Vinod V Tuliani
Michael A Brandley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Vinod V Tuliani, Michael A Brandley filed Critical Glaxo Group Ltd
Publication of WO2006089215A2 publication Critical patent/WO2006089215A2/fr
Publication of WO2006089215A3 publication Critical patent/WO2006089215A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention porte, entre autres, sur une composition pharmaceutique qui se présente sous la forme d'un comprimé contenant une quantité efficace d'un composé A, un polymère gonflant, un polymère de matrice, un agent flottant, et facultativement un diluant, un liant, un glissant, et/ou un lubrifiant. L'invention porte aussi sur un procédé de traitement ou de prévention de troubles thromboemboliques consistant à administrer une quantité efficace de la composition à un patient qui en a besoin.
PCT/US2006/005821 2005-02-18 2006-02-17 Compositions pharmaceutiques et procedes associes WO2006089215A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65427905P 2005-02-18 2005-02-18
US60/654,279 2005-02-18
US69612105P 2005-07-01 2005-07-01
US60/696,121 2005-07-01

Publications (2)

Publication Number Publication Date
WO2006089215A2 WO2006089215A2 (fr) 2006-08-24
WO2006089215A3 true WO2006089215A3 (fr) 2006-11-23

Family

ID=36917125

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/005821 WO2006089215A2 (fr) 2005-02-18 2006-02-17 Compositions pharmaceutiques et procedes associes

Country Status (4)

Country Link
AR (1) AR054226A1 (fr)
PE (1) PE20061010A1 (fr)
TW (1) TW200640449A (fr)
WO (1) WO2006089215A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169838A (en) * 1989-09-22 1992-12-08 Fournier Industrie Et Sante Benzopyranone-β-D-thioxylosides and their use in therapy
US6602899B1 (en) * 1999-11-17 2003-08-05 Fournier Industrie & Sante β-D-5 thioxylose derivatives, preparation method and therapeutic use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169838A (en) * 1989-09-22 1992-12-08 Fournier Industrie Et Sante Benzopyranone-β-D-thioxylosides and their use in therapy
US6602899B1 (en) * 1999-11-17 2003-08-05 Fournier Industrie & Sante β-D-5 thioxylose derivatives, preparation method and therapeutic use

Also Published As

Publication number Publication date
WO2006089215A2 (fr) 2006-08-24
AR054226A1 (es) 2007-06-13
TW200640449A (en) 2006-12-01
PE20061010A1 (es) 2006-11-11

Similar Documents

Publication Publication Date Title
WO2008124085A3 (fr) Méthodes d'utilisation de combinaisons d'inhibiteurs de mek et de jak-2
WO2008063768A3 (fr) Compositions et procédés pour traiter des maladies métaboliques
WO2007082808A3 (fr) Thiazoles en tant qu'inhibiteurs de 11 beta-hsd1
WO2007015824A3 (fr) Nouveaux inhibiteurs macrocycliques de la multiplication du virus de l’hépatite c
WO2007024949A3 (fr) Agonistes d'alpha 2c adrenorecepteur
WO2008067127A3 (fr) Matrice polymere insoluble dans l'eau permettant la liberation de medicament
WO2007000778A3 (fr) Compositions pharmaceutiques a liberation modifiee et leurs procedes
WO2007122580A3 (fr) Compositions et méthodes utiles dans le traitement de maladies respiratoires
WO2008005511A8 (fr) Nouveaux inhibiteurs de la réplication du virus de l'hépatite c
WO2007143607A3 (fr) Procédé de traitement de la vaginite atrophique
WO2007103719A3 (fr) MODULATEURS DE LA 11-β-HYDROXYSTÉROÏDE DÉSHYDROGÉNASE DE TYPE 1, LEURS COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCÉDÉS D'UTILISATION
WO2007084314A3 (fr) MODULATEURS de la 11-ß HYDROXYSTEROIDE DESHYDROGENASE DE TYPE 1, LEURS COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCEDES D'UTILISATION
WO2008137779A3 (fr) Inhibiteurs macrocycliques innovants de la réplication du virus de l'hépatite c
WO2007125501A3 (fr) Compositions et procédés utiles pour le traitement d'une maladie respiratoire
WO2007129195A3 (fr) 4-pyrimidine-5-amino-pyrazoles
TW200716628A (en) Novel compounds
EP1880719A3 (fr) Composition pour la prophylaxie ou le traitement des infections du système urinaire et son procédé associé
WO2006038226A3 (fr) Compositions de metformine fortement compressibles a liberation controlee
WO2007127726A3 (fr) Inhibiteurs de la 11-bêta-hydroxystéroïde déshydrogénase 1
WO2008092006A3 (fr) Compositions antimicrobiennes
WO2006127637A3 (fr) Melange compressible, compositions pharmaceutiques comprimees et procede permettant de les preparer
NZ609344A (en) Method for treatment of diarrhea-predominant irritable bowel syndrome
WO2006074265A3 (fr) Therapie combinee et compositions pharmaceutiques utilisees dans le traitement des troubles inflammatoires
WO2007067519A3 (fr) Utilisation de neurotransmetteurs et de neuropeptides pour le traitement de maladies de secheresse oculaire et de conditions associees
WO2007112272A3 (fr) Formulations de diclofénac et de cyclodextrine bêta à faible dosage

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06735472

Country of ref document: EP

Kind code of ref document: A2